HTGM Annual FCF
-$18.43 M
-$1.28 M-7.45%
31 December 2022
Summary:
As of February 5, 2025, HTGM annual free cash flow is -$18.43 million, with the most recent change of -$1.28 million (-7.45%) on December 31, 2022. During the last 3 years, it has fallen by -$631.70 thousand (-3.55%).HTGM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HTGM Quarterly FCF
-$4.37 M
-$2.35 M-115.98%
31 March 2023
Summary:
As of February 5, 2025, HTGM quarterly free cash flow is -$4.37 million, with the most recent change of -$2.35 million (-115.98%) on March 31, 2023. Over the past year, it has increased by +$1.58 million (+26.53%).HTGM Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HTGM TTM FCF
-$16.85 M
+$1.58 M+8.56%
31 March 2023
Summary:
As of February 5, 2025, HTGM TTM free cash flow is -$16.85 million, with the most recent change of +$1.58 million (+8.56%) on March 31, 2023. Over the past year, it has increased by +$1.80 million (+9.63%).HTGM TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HTGM Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.5% | +26.5% | +9.6% |
| 3 y3 years | -3.5% | -10.5% | -4.9% |
| 5 y5 years | -4.8% | -38.3% | +5.3% |
HTGM Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +110.7% | -115.7% | -301.0% |
HTG Molecular Diagnostics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$4.37 M(+116.0%) | -$16.85 M(-8.6%) |
| Dec 2022 | -$18.43 M(+7.5%) | -$2.02 M(-56.1%) | -$18.43 M(-7.2%) |
| Sept 2022 | - | -$4.60 M(-21.4%) | -$19.85 M(+0.2%) |
| June 2022 | - | -$5.86 M(-1.5%) | -$19.81 M(+6.2%) |
| Mar 2022 | - | -$5.95 M(+72.7%) | -$18.65 M(+8.7%) |
| Dec 2021 | -$17.15 M(+2.4%) | -$3.44 M(-24.6%) | -$17.15 M(-0.8%) |
| Sept 2021 | - | -$4.57 M(-2.7%) | -$17.29 M(+0.6%) |
| June 2021 | - | -$4.69 M(+5.4%) | -$17.18 M(-0.3%) |
| Mar 2021 | - | -$4.45 M(+24.2%) | -$17.24 M(+3.0%) |
| Dec 2020 | -$16.75 M(-5.9%) | -$3.58 M(-19.5%) | -$16.75 M(-3.6%) |
| Sept 2020 | - | -$4.45 M(-6.2%) | -$17.37 M(-0.3%) |
| June 2020 | - | -$4.75 M(+20.1%) | -$17.42 M(+8.5%) |
| Mar 2020 | - | -$3.96 M(-6.0%) | -$16.06 M(-9.8%) |
| Dec 2019 | -$17.80 M(+26.0%) | -$4.21 M(-6.6%) | -$17.80 M(+9.5%) |
| Sept 2019 | - | -$4.51 M(+32.9%) | -$16.26 M(+5.8%) |
| June 2019 | - | -$3.39 M(-40.5%) | -$15.37 M(-7.7%) |
| Mar 2019 | - | -$5.70 M(+113.6%) | -$16.66 M(+18.0%) |
| Dec 2018 | -$14.12 M | -$2.67 M(-26.3%) | -$14.12 M(-4.4%) |
| Sept 2018 | - | -$3.62 M(-22.6%) | -$14.78 M(-5.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | -$4.68 M(+48.0%) | -$15.68 M(-2.3%) |
| Mar 2018 | - | -$3.16 M(-4.9%) | -$16.05 M(-8.8%) |
| Dec 2017 | -$17.59 M(-27.2%) | -$3.32 M(-26.6%) | -$17.59 M(-8.8%) |
| Sept 2017 | - | -$4.53 M(-10.3%) | -$19.28 M(-0.5%) |
| June 2017 | - | -$5.04 M(+7.3%) | -$19.37 M(-14.0%) |
| Mar 2017 | - | -$4.70 M(-6.1%) | -$22.54 M(-6.8%) |
| Dec 2016 | -$24.18 M(+17.5%) | -$5.01 M(+8.4%) | -$24.18 M(+0.3%) |
| Sept 2016 | - | -$4.62 M(-43.7%) | -$24.12 M(-387.6%) |
| June 2016 | - | -$8.21 M(+29.4%) | $8.39 M(-137.8%) |
| Mar 2016 | - | -$6.34 M(+28.3%) | -$22.17 M(+7.7%) |
| Dec 2015 | -$20.58 M(+48.6%) | -$4.94 M(-117.7%) | -$20.58 M(+10.3%) |
| Sept 2015 | - | $27.88 M(-171.9%) | -$18.66 M(-62.9%) |
| June 2015 | - | -$38.76 M(+714.5%) | -$50.36 M(+242.6%) |
| Mar 2015 | - | -$4.76 M(+57.3%) | -$14.70 M(+6.1%) |
| Dec 2014 | -$13.85 M(+9.9%) | -$3.03 M(-20.7%) | -$13.85 M(+27.9%) |
| Sept 2014 | - | -$3.82 M(+23.0%) | -$10.83 M(+54.4%) |
| June 2014 | - | -$3.10 M(-20.7%) | -$7.01 M(+79.3%) |
| Mar 2014 | - | -$3.91 M | -$3.91 M |
| Dec 2013 | -$12.60 M(+44.0%) | - | - |
| Dec 2012 | -$8.75 M | - | - |
FAQ
- What is HTG Molecular Diagnostics annual free cash flow?
- What is the all time high annual FCF for HTG Molecular Diagnostics?
- What is HTG Molecular Diagnostics annual FCF year-on-year change?
- What is HTG Molecular Diagnostics quarterly free cash flow?
- What is the all time high quarterly FCF for HTG Molecular Diagnostics?
- What is HTG Molecular Diagnostics quarterly FCF year-on-year change?
- What is HTG Molecular Diagnostics TTM free cash flow?
- What is the all time high TTM FCF for HTG Molecular Diagnostics?
- What is HTG Molecular Diagnostics TTM FCF year-on-year change?
What is HTG Molecular Diagnostics annual free cash flow?
The current annual FCF of HTGM is -$18.43 M
What is the all time high annual FCF for HTG Molecular Diagnostics?
HTG Molecular Diagnostics all-time high annual free cash flow is -$8.75 M
What is HTG Molecular Diagnostics annual FCF year-on-year change?
Over the past year, HTGM annual free cash flow has changed by -$1.28 M (-7.45%)
What is HTG Molecular Diagnostics quarterly free cash flow?
The current quarterly FCF of HTGM is -$4.37 M
What is the all time high quarterly FCF for HTG Molecular Diagnostics?
HTG Molecular Diagnostics all-time high quarterly free cash flow is $27.88 M
What is HTG Molecular Diagnostics quarterly FCF year-on-year change?
Over the past year, HTGM quarterly free cash flow has changed by +$1.58 M (+26.53%)
What is HTG Molecular Diagnostics TTM free cash flow?
The current TTM FCF of HTGM is -$16.85 M
What is the all time high TTM FCF for HTG Molecular Diagnostics?
HTG Molecular Diagnostics all-time high TTM free cash flow is $8.39 M
What is HTG Molecular Diagnostics TTM FCF year-on-year change?
Over the past year, HTGM TTM free cash flow has changed by +$1.80 M (+9.63%)